There was no statistically significant difference in the median ( 25 % -75 % ) VAS pain scores between women administered vaginal misoprostol ( median , 6.7 cm ; range , 4.7-9 cm ) and the control group ( median , 6.7 cm ; range , 4.6-8 .8 cm ) during the HSG .